Long-term treatment of deep vein thrombosis or pulmonary embolism in patients with cancer

Long-term treatment for cancer patients with deep venous thrombosis or pulmonary embolism: an international registry

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON28644

Enrollment

200

Registered

2015-06-16

Start date

2015-07-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary embolism deep vein thrombosis venous thromboembolism cancer kanker longembolie diep veneuze trombose veneuze trombo-embolie

Interventions

none

Eligibility

Inclusion criteria

Inclusion criteria: Patients with cancer (excluding non-melanoma skin cancer) Confirmed diagnosis of acute pulmonary embolism or deep venous thrombosis

Exclusion criteria

Exclusion criteria: legal age limitations

Design outcomes

Primary

Measure	Time frame
recurrence of VTE bleeding events mortality	—

Secondary

Measure	Time frame
risk factors of recurrent VTE	—

Contacts

Public ContactIT Wilts

Dept of Vascular Medicine - University Medical Center Groningen

examinethrombosis@umcg.nl+31503612943

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)